17-year-old girl dies after 2nd dose “too soon” to find out if vaccine is involved

A 17-year-old girl attending an agricultural high school in Gordon (Bouche-du-Rhône, France) died a few days after being given the second dose of the Fischer vaccine. Earlier, he was taken to a hospital in Aix-en-Provence, where he was subjected to a series of ailments in the institution’s refinery.

His case has already been reported to the National Drug Safety Agency (ANSM), which is responsible for monitoring “adverse effects” – the formula here is very weak – ranging from the vaccine to Govit-19 to 12-18 years, L’Union writes.

The physician responsible for signing the law referred to the “medical-legal prohibition” as a matter of routine practice in which the circumstances of a death must be clarified, especially in the event of the sudden death of a young person.

The final results of the autopsy ordered by the attorney are not yet known and should not be for several days. “The first cause is pulmonary embolism, but it is still necessary to look for its origin,” said Ax-En-Provence Republican attorney Achilles Creacitis Wednesday (September 29). Provence.

In addition to pulmonary embolism (pulmonary embolism), other tests should be performed to determine if the young woman is predisposed to coagulation disorders (especially taking the estrogen-progestogen pill) Release. Although anti-viral vector vaccines (such as the AstraZeneca or Janssen vaccines) have been well established to increase the risk of certain thromboses in young patients, this has not yet been proven for messenger RNA vaccines – only approved. 12-17 year olds.

The ANSM immediately assured the safety of the vaccine for this age group. “As of September 16, 2021, more than 4.5 million of them had received at least one injection. A total of 591 cases have been reported, including 206 severe cases after vaccination. No specific signal was identified in the younger subjects,” it said. LCI.